ONE MORE PASSENGER ON THE BOARD OF DEHEALTH!
DeHealth is pleased to announce the addition of Anita Lane to the global DeHealth team who will serv…
🇬🇧 We are thrilled to share the news of DeHealth's participation in LSX World Congress 2023 in London. The event, known for bringing together key players from the life science and healthcare sectors, proved to be an exceptional platform for DeHealth to showcase its groundbreaking innovations and advancements in the field.
At the LSX World Congress, DeHealth was represented by our Advisor Philippe Gerwill, a distinguished expert and thought leader in the healthcare industry. With his extensive knowledge and experience, Mr. Gerwill played a pivotal role in highlighting DeHealth's vision and strategic direction during the event, also attended the congress in his additional role as an HLS consultant for Tata Elxsi.
More than 2,000 attendees from diverse sectors, including pharmaceuticals, biotechnology, digital health, and investment, participated in the LSX World Congress, offering a wide range of networking opportunities for DeHealth. Several leading venture capital firms and angel investors recognized the immense potential of DeHealth's innovations and expressed their intent to support the company's growth. The breakthrough AI-based technology offered by DeHealth can save countless lives through early detection and more accurate diagnosis of critical conditions.
👨💼 Philippe Gerwill - “The event brought together CEOs and senior decision-makers from the world's most innovative biopharma, medtech, and healthtech companies with investors, senior BD&L teams, R&D leaders, and industry KOLs. The aim was to share best practices, forge partnerships and investments, and put capital and ideas to work to create the world's future medicines and improve patient outcomes.”
Join us on social networks and find out the most interesting insights of the project, explore the industry and keep abreast of all the latest news:
Twitter | LinkedIn | Facebook | Instagram | Telegram | YouTube